(Q38889364)

7 September 2017

title

Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary (English)

1 reference

7 September 2017

0 references

1 reference

Nozomu Yanaihara

1

1 reference

7 September 2017

Yukihiro Hirata

2

1 reference

7 September 2017

Noriko Yamaguchi

3

1 reference

7 September 2017

Yukiko Noguchi

4

1 reference

7 September 2017

Misato Saito

5

1 reference

7 September 2017

Chie Nagata

6

1 reference

7 September 2017

Satoshi Takakura

7

1 reference

7 September 2017

Kyosuke Yamada

8

1 reference

7 September 2017

Aikou Okamoto

9

1 reference

7 September 2017

publication date

9 April 2015

1 reference

7 September 2017

published in

Molecular Carcinogenesis

1 reference

7 September 2017

volume

55

1 reference

7 September 2017

issue

5

1 reference

7 September 2017

page(s)

832-841

1 reference

Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010.

7 September 2017

cites work

1 reference

IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer

21 January 2018

1 reference

Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes.

21 January 2018

1 reference

Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma

21 January 2018

1 reference

Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells

21 January 2018

1 reference

Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancer

21 January 2018

1 reference

Interleukin-6 as a therapeutic target in human ovarian cancer

21 January 2018

1 reference

A phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors

21 January 2018

1 reference

Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays

21 January 2018

1 reference

Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer

21 January 2018

1 reference

Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells

21 January 2018

1 reference

Interleukin-6 signaling pathway in targeted therapy for cancer

21 January 2018

1 reference

Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies

21 January 2018

1 reference

Interleukin-6/interleukin-6 receptor pathway as a new therapy target in epithelial ovarian cancer.

21 January 2018

1 reference

Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine

21 January 2018

1 reference

New perspectives on molecular targeted therapy in ovarian clear cell carcinoma.

21 January 2018

1 reference

Clear cell carcinoma of the ovary: a review of the literature

21 January 2018

1 reference

The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody

21 January 2018

1 reference

Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma.

21 January 2018

1 reference

Antitumor effect of humanized anti-interleukin-6 receptor antibody (tocilizumab) on glioma cell proliferation. Laboratory investigation

21 January 2018

1 reference

siRNA and innate immunity

21 January 2018

1 reference

Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling

21 January 2018

1 reference

Expression of soluble interleukin-6 receptor in malignant ovarian tissue

21 January 2018

1 reference

Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas.

21 January 2018

1 reference

Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MC.22325

1 reference

7 September 2017

1 reference